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Background: Otitis-prone children can present some distinctive clinical patterns and
although a number of known risk factors for recurrent acute otitis media (RAOM) are
known, no dedicated epidemiological models have been developed to explain clinical
heterogeneity.
Methods: A preliminary retrospective pilot study was planned to evaluate the
possible effect of allergic disease in the development of different disease phenotypes
in otitis-prone children aged 3–10 years, particularly the absence (simple RAOM), or
presence of episodes of otitis media with effusion between acute infections (RAOM with
OME).
Results: Analysis was based on the data contained in 153 charts (55.6% males, mean
age of 59.4 ± 16.4 months). 75.8% of children had a simple RAOM and 24.2% a
RAOM with OME. Atopy or allergy were documented in respectively 47.7 and 41.3%
of children considered as a whole. The prevalence of atopy or allergy was significantly
higher in the children with a RAOM with OME (atopy: 73.0 vs. 39.5%, p < 0.001; allergy:
60.0 vs. 36.1%, p = 0.049), who also more frequently showed adenoidal hypertrophy
(p = 0.016), chronic adenoiditis (p = 0.007), conductive hearing loss (p = 0.004), and
impaired tympanometry (p < 0.001).
Conclusions: These data suggest that children with a RAOM with OME are clinically
different from children with simple RAOM, as they have a more complex clinical
presentation that includes not only adenoidal disease and audiological impairment, but
also an underlying allergy or atopy. The possibility that the factors mentioned above
may be differently involved in the heterogeneous clinical manifestations occurring in
otitis-prone children needs to be further investigated in ad hoc epidemiological studies.
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INTRODUCTION
Recurrent and chronic middle ear diseases are frequently encountered in otorhinolaryngological
and pediatric clinical practice, and they often require specialist consultations and antibiotic
prescriptions (1–3). The most frequent of these is acute otitis media (AOM), which may also
be the most frequent bacterial disease affecting infants and young children (4) as almost all
children have experienced at least one episode by the age of 3 years, and about one-third have
experienced three or more episodes (5). In addition, it has been estimated that up to 90%
of children experience least one episode of otitis media with effusion (OME, defined as the
presence of middle ear fluid for more than 3 months without any sign or symptom of ear
infection) (6) before reaching school age, with most cases occurring by the age of 2 years (7–9).
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at Finally, some children are predisposed to recurrent AOM
(RAOM: i.e., at least three documented and distinct AOM
episodes in the preceding 6 months, or at least four in the
preceding 12 months) (10), whose negative medical, social
and economic effects can considerably worsen their and
their parents’ quality of life. In addition, some patients may
develop complicated disease with possible severe and sometimes
life-threatening events requiring urgent management such as
mastoiditis, meningitis, and cerebral abscess.
Although the different clinical manifestations of recurrent or
chronic middle ear inflammation, including RAOM and OME,
have distinctive clinical and histopathological features, they
sometimes overlap and are generally considered as belonging
to a continuum of diseases affecting the so-called “otitis-prone”
children (11). However, on the basis of our clinical experience
and as previous described (12), we believe that it is possible
to identify some distinctive patterns within this nosological
entity.
There are a number of known risk factors for the development
of chronic or recurrent middle ear inflammation, such as
a genetic predisposition, a young age, male gender, little or
no breastfeeding, parental smoking, the use of a pacifier or
push-and-pull plastic bottle caps, day-care attendance, allergy,
nasopharyngeal bacterial biofilm, and the presence of an older
sibling (2, 13–18), but no dedicated epidemiological models have
been developed to explain the clinical heterogeneity of this subset
of diseases, and there is no unanimous consensus about the
best individual approach to the single phenotypes. Moreover,
although various interventions have been proposed as a means
of reducing the risk of new infectious exacerbations in otitis-
prone children (2, 3, 19–22), none of these is completely effective,
and their benefits in terms of preventing RAOM have not been
precisely quantified (2). We speculate that this may be related to
the fact that different risk factors (or combinations of risk factors)
can give rise to different clinical phenotypes that require different
prophylactic interventions.
The aim of this preliminary retrospective pilot study (the
first of a planned series of studies designed to investigate
whether traditional risk factors differently influence particular
disease patterns) was to evaluating the possible effect of allergic
disease in the development of different disease phenotypes
in otitis-prone children, particularly the presence of episodes
of OME between acute infections, and the presence of
spontaneous tympanic membrane perforations during episodes
of AOM.
MATERIALS AND METHODS
Study Design and Setting
This retrospective chart review of prospectively recruited otitis-
prone children was carried out at Milan University’s Department
of Clinical Sciences and Community Health and Department of
Pathophysiology and Transplantation in September 2017.
The protocol was approved by our local Ethics Committee of
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
and was conducted in accordance with the principles of good
clinical practice.
Study Subjects
The study involved the charts of children aged 3–10 years who
had attended our tertiary outpatient clinic of upper respiratory
tract infection between November 2016 and May 2017. The
children had been referred to the clinic by the pediatricians who
had dealt with their initial episodes of AOM but were unable to
manage recurrences effectively.
The children were considered otitis-prone if they had a history
of RAOM with or without OME between AOM episodes (11).
The episodes of AOM had to be documented by an experienced
physician and reported in the children’s medical records as any
combination of fever, earache, irritability, and hyperemia or
opacity accompanied by bulging of the tympanic membrane or
otorrhea; at least two episodes had to be supported by otoscopic
and tympanometric findings. RAOMwas defined as at least three
episodes in the preceding 6 months, or at least four episodes
in the preceding 12 months (10), and OME as the presence
of middle ear effusion for at least 3 months without any signs
of concomitant acute middle ear inflammation, documented by
means of pneumatic otoscopy and tympanometry (6).
The exclusion criteria were concomitant systemic diseases;
craniofacial, neuromuscular, immunological, syndromic, or
defined genetic abnormalities; chronic eardrum perforation;
previous ear surgery (including ventilation tube placement) or
adenoidectomy; neurosensory hearing loss; immunomodulatory
treatment; vitamin D supplementation; the administration of any
complementary and alternative medicines; and clinical signs or a
history of suspected laryngo-pharyngeal reflux.
Interventions
The retrospective chart review considered the children’s
demographic data and clinical history, with particular reference
to the presence of allergy or atopy and their phenotypic pattern
of disease (12). Allergy had to be documented by a positive skin
prick or radio-allergosorbent test, and atopy by increased serum
IgE levels within the previous 12 months with concomitant
symptoms of asthma and\or rhinocongiuntivitis, and\or eczema.
The children with RAOM but no OME between episodes were
classified as having a simple RAOM, and those with RAOM
and episodes of OME between acute exacerbations as RAOM
with OME. Children were clinically evaluated during acute
episodes and then 7 days, 1 month, and 3 months later with
pneumatic otoscopy and tympanometry. The group RAOM with
OME included only children without any evidence of complete
clearance of the middle ear from effusion at any of the follow-up
visits, documented by impaired findings at tympanometry,
i.e., children with evidence at pneumatic otoscopy and/or
tympanometry of middle ear effusion persisting for at least 3
months without any signs of concomitant acute middle ear
inflammation.
The presence of recurrent spontaneous tympanic membrane
perforation (RSTMP), defined as purulent ear discharge
and/or otoscopic detection of tympanic membrane perforation
occurring during ≥75% of AOM episodes (12), was also
recorded.
The other data considered were age at the time of onset and
at the time of satisfying the diagnostic criteria for RAOM; the
Frontiers in Pediatrics | www.frontiersin.org 2 December 2018 | Volume 6 | Article 383
Torretta et al. Otitis Media: Phenotype Profiling and Allergy
number of AOM episodes since birth and in the previous 3, 6
and 12months; the presence of hypertrophic adenoids or chronic
adenoiditis revealed by flexible nasopharyngeal fiberendoscopy
(23), and the results of an audiometry test (i.e., pure tone
or conditioned play audiometry and tympanometry) carried as
previously described (24). Hypertrophic adenoids were defined
as the presence of Cassano grade ≥3 adenoidal pads (25), and
chronic adenoiditis as the presence of hypertrophic adenoids
with ongoing nasopharyngeal inflammations or infections (at
least three episodes of acute adenoiditis requiring antibiotic
therapy in a period of 6 months, or at least four episodes in a
period of 12 months) (26).
Finally, a record was made of the factors known to influence
the development of RAOM (including a family history of allergy,
little or no breast-feeding, the use of a pacifier or push-and-pull
plastic bottle caps, parental smoking, pneumococcal conjugate
and influenza vaccination, day-care attendance, and the presence
and number of older siblings) (2, 13, 16–18).
Statistical Analysis
The sample size was computed considering published data
regarding the prevalence of atopy in children with middle ear
disease (27); assuming a standard deviation of 0.15, it was
calculated that 34 subjects for each group would lead to a beta
error margin of 0.20, an alpha value of 0.05, and a power of 80%.
The statistical analysis was mainly designed to detect possible
association between the clinical phenotypic pattern of disease
and the presence of allergy or atopy, and the effect of possible
confounders on this relationship.
The results are given as absolute numbers and percentages,
or arithmetical mean values ± standard deviation. Dichotomous
outcomes were analyzed using contingency table analysis and Chi
squared test, and continuous variables using Wilcoxon-Mann-
Whitney test. Poisson’smodels for logisticmultivariate regression
analysis were used to assess the effect of possible confounders.
The data were analyzed using STATA 10.0 software (StataCorp,
College Station, TX, USA); a p-value of <0.05 was considered
statistically significant.
RESULTS
The final analysis was based on the data contained in 153 charts
relating to 85 males (55.6%) and 68 females (44.4%) with a mean
age of 59.4 ± 16.4 months. One hundred and sixteen children
(75.8%) had a simple RAOM and 37 (24.2%) a RAOM with
OME. Recurrent spontaneous tympanic membrane perforation
occurred in 54 children (35.3%), and atopy or allergy were
documented in respectively 73 (47.7%) and 38 (41.3%) (Table 1).
The prevalence of atopy or allergy was significantly higher
in the children with a RAOM with OME (atopy: 73.0 vs.
39.5%, p < 0.001; allergy: 60.0 vs. 36.1%, p = 0.049), who also
more frequently showed adenoidal hypertrophy (p = 0.016),
chronic adenoiditis (p = 0.007), conductive hearing loss (p =
0.004), and impaired tympanometry (p < 0.001). The other
main demographic and clinical characteristics were comparable
in the two groups (Table 1). These factors were confirmed to
be independent predictors at logistic multivariate regression
analysis (Table 2).
There was no statistically significant association between
the presence of allergy or atopy and chronic adenoiditis or
adenoidal hypertrophy: chronic adenoiditis affected respectively
40.0 and 40.7% of the allergic and non-allergic children, and
43.3 and 48.6% of the atopic and non-atopic children; adenoidal
hypertrophy was detected in 51.7 and 30.8% of the allergic and
non-allergic children, and in 42.2 and 47.2% of the atopic and
non-atopic children.
Conductive hearing loss was more frequently detected among
the children with allergy (39.5 vs. 9.4%, p= 0.001), but there was
no significant difference between atopic and non-atopic children
(26.0 vs. 20.0%).
The children with allergy satisfied the diagnostic criteria for
RAOM slightly but not significantly later than the non-allergic
children (36.2 ± 2.8 vs. 30.3 ± 2.2 months), and there was no
difference between the atopic and non-atopic children (32.8 ±
1.9 vs. 30.8± 1.7 months).
There was no significant association between allergy or atopy
and RSTMP, which occurred in respectively 51.8 and 48.1% of
the atopic and non-atopic children, and in 43.2 and 56.8% of the
allergic and non-allergic children.
DISCUSSION
This first study evaluating the role of allergic/atopic status in
otitis-prone children with RAOM with (RAOM with OME) or
without OME (simple RAOM) between episodes is part of the
broader Epidemiology and Phenotypes In Children with Otitis
(EPICO) project aimed at assessing the impact of the most
frequent traditional and newly described risk factors for recurrent
or chronic middle ear inflammation on phenotypes (12).
The importance of distinguishing otitis media phenotypes
has previously been discussed by us (12) and Bhutta et al.
(28) who has constructed sophisticated mathematical
models to represent the clinical inter-relations between
individual clinical manifestations and the impact of variables,
such as upper respiratory tract infections in a new disease
scenario.
The findings of this preliminary retrospective pilot study show
that the prevalence of allergy or atopy patients was significantly
higher in otitis-prone children with a RAOM with OME than
in those with a simple RAOM: atopy was found in 73.0% of the
children with a RAOM with OME as against 39.5% of those with
a simple RAOM, and allergy was found in respectively 60.0 and
36%, which suggests that allergy may differentially account for
different phenotypic pattern of disease in children with RAOM,
and may be involved in the development of a RAOM with
OME.
Allergy and atopy have been previously investigated as
possible risk factors for AOM and OME (18, 29–37). However,
although there is clinical, mechanical and therapeutic evidence
supporting their possible effect on the pathogenesis of recurrent
or chronic middle ear inflammation, there is still a lack of
strong epidemiological evidence, and the results obtained in
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TABLE 1 | Demographic and clinical characteristics of the study population as a whole and by the clinical phenotypic pattern of disease.
Characteristics Total
(n = 153)
Simple RAOM
(n = 116 pts)
RAOM with OME
(n = 37)
p-value
Mean age ± SD, months 59.4 ± 16.4 59.0 ± 1.5 60.6 ± 2.8 n.s.
Males 85 (55.6%) 69 (59.5%) 16 (43.24%) n.s.
RSTMP 54 (35.3%) 43 (37.1%) 11 (29.7) n.s.
Increased IgE levels 73 (47.7%) 46 (39.7%) 27 (73.0%) <0.001
Allergy 38 (41.3%) 26 (36.1%) 12 (60.0%) 0.049
Mean age at onset ± SD, months 20.2 ± 13.3 20.7 ± 1.5 19.7 ± 1.5 n.s.
Mean age at diagnosis ± SD, months 31.8 ± 16.0 30.3 ± 2.2 36.2 ± 2.8 n.s.
Mean No. of AOMs since birth ± SD 9.6 ± 4.6 9.4 ± 0.5 9.7 ± 0.5 n.s.
Mean No. of AOMs in previous 3 months ± SD 1.6 ± 0.8 1.4 ± 0.6 1.7 ± 0.5 n.s.
Mean No. of AOMs in previous 6 months ± SD 3.6 ± 1.6 3.4 ± 1.2 3.6 ± 1.8 n.s.
Mean No. of AOMs in previous 12 months ± SD 4.5 ± 2.1 4.3 ± 2.0 4.6 ± 2.4 n.s.
Adenoidal hypertrophy 68 (44.4%) 41 (35.3%) 27 (73.0%) 0.016
Chronic adenoiditis 52 (34.0%) 31 (26.7%) 21 (80.8%) 0.007
Conductive hearing loss (ad endo) 35 (22.9%) 20 (17.2%) 15 (40.5%) 0.004
Impaired tympanometry* 79 (51.6%) 49 (42.2%) 30 (81.1%) <0.001
Family history of allergy 58 (37.9%) 44 (37.9%) 14 (37.8%) n.s.
Prematurity 14 (9.1%) 10 (8.6%) 4 (10.8%) n.s.
Little or no breastfeeding 57 (37.2%) 44 (37.9%) 13 (35.1%) n.s.
Day-care attendance (%) 149 (96.7%) 11 (95.7%) 37 (100%) n.s.
Use of pacifier 61 (39.9%) 50 (43.1%) 11 (29.7%) n.s.
Use of push-and-pull plastic bottle caps use 66 (43.1%) 54 (46.5%) 12 (32.4%) n.s.
Parental smoking 68 (44.4%) 55 (47.4%) 13 (35.1%) n.s.
Presence of older siblings 65 (42.5%) 48 (41.4%) 17 (45.9%) n.s.
Mean No. of siblings ± SD 1.5 ± 0.7 1.5 ± 0.1 1.4 ± 0.1 n.s.
PVC7 immunization 136 (88.9%) 101 (87.1%) 35 (94.6%) n.s.
Influenza immunisation 60 (39.5%) 43 (37.4%) 17 (45.9%) n.s.
SD, standard deviation; RAOM, recurrent acute otitis media; OME, otitis media with effusion; n.s., not significant; RSTMP, recurrent spontaneous tympanic membrane perforation; AOM,
acute otitis media; PVC7, pneumococcal conjugate vaccine; *Type B or C-tympanogram in at least one ear.
previously published studies are conflicting. One meta-analysis
(29) published in 1996 pooled the results of three studies
(30–32) involving a total of 1,362 children failed to find any
statistically significant impact of atopy or allergy on AOM
(relative risk 1.23; 95% confidence interval 0.94–1.61), and
the same is true of the studies by Pukander et al. (33) and
Staaberg et al. (34). However, Kvaerner et al. (35) used a
cross-sectional questionnaire to investigate 40,000 randomly
selected Norwegian adults and found that surgery for RAOM
and otitis media was more frequent in the respondents with
allergy, and Kramer et al. (36) found that atopic symptoms
were approximately four times more frequent in children
with OME who were candidates for tympanostomy tube
placement than in control children undergoing general pediatric
surgery. Beside this, some evidences support the hypothesis
that OME should be enumerated among allergic manifestations,
considering that middle ear mucosa has been found to have the
same active intrinsic immunologic responsiveness to antigens
as the upper and lower respiratory ectodermal-derived tract
epithelium (38). Moreover, it has been hypothesized that allergic
inflammation into the middle ear during OME would depend
not only on activation of secretory immunity following direct
TABLE 2 | Results of multivariate logistic regression models.
Variable P-value Pseudo R2
Increased IgE level <0.001 0.57
Allergy <0.001 0.60
Adenoidal hypertrophy 0.003 0.53
Chronic adenoiditis 0.002 0.52
allergen transport, but also on humoral and cell-mediated
reaction (39).
We also found that adenoidal disease (adenoidal hypertrophy
or chronic adenoiditis) was significantly more prevalent among
children with RAOM with OME than among those with a
simple RAOM (adenoidal hypertrophy: 73.0 vs. 35.3%; chronic
adenoiditis: 80.8 vs. 26.7%). However, as there was no significant
association between the presence of atopy/allergy and adenoidal
disease, it can be assumed that allergic status was not directly
related to the development of nasopharyngeal disease in our
children. The possible causative role of adenoidal disease in otitis-
prone children has been previously postulated by Salah et al. (40)
who identified adenoidal hypertrophy as a possible risk factor
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FIGURE 1 | Risk factors for phenotypic pattern of disease characterized by the presence or recurrent acute otitis media with persisting otitis media with effusions
among acute episodes (RAOM with OME) in children aged ≥3 years (PVC7, pneumococcal conjugate vaccination).
for treatment failure and infectious recurrences in children with
RAOM in a retrospective study of 340 otitis-prone infants.
Our findings confirm that children with a RAOM with OME
more frequently have impaired hearing than children with simple
RAOM, and show that they satisfy the diagnostic criteria for
RAOM slightly later, at a mean age of about 36 months. The latter
finding is particularly interesting because, as most of the clinical
manifestations of allergy in atopic children appear after the age
of 3 years (41), we are tempted to hypothesize that a RAOM
with OME could be such a manifestation, which is why we only
recruited children aged >3 years.
Taken together, these data suggest that children with a RAOM
with OME are clinically different from children with simple
RAOM, as they have a more complex clinical presentation that
includes not only adenoidal disease and audiological impairment,
which may pre-dispose them to long-term functional sequelae
and become a major cause of surgical treatment, but also an
underlying allergy or atopy requiring second-level assessment
and anti-allergic therapy. However, the possible causative role
of an allergic status (or adenoidal disease) in the pathogenesis
of RAOM with OME goes beyond the scope of this preliminary
retrospective study, and it should be addressed by ad hoc
epidemiological studies.
Possible limitations of the present study lie in its retrospective
nature which may partially bias our results, and in the reduced
sample size; therefore, prospective controlled trials would be
welcome to confirm our findings.
The possibility that the factors mentioned above may be
differently involved in the heterogeneous clinical manifestations
occurring in otitis-prone children needs to be further investigated
in ad hoc epidemiological studies. If our theory is confirmed, it
would have important clinical and therapeutic consequences as it
would allow dedicated diagnostic, therapeutic and prophylactic
interventions to be designed for each clinical pattern.
Finally, the nosological and epidemiological concepts
underlying our view of childhood recurrent and chronic middle
ear disease could be updated, and the famous illustration of the
risk factors for pediatric RAOM known as Rovers’ daisy (42)
could ideally be reproduced in serial copies for each phenotypic
pattern of disease and different ages with the petals’ size being
weighted on the basis of their etiological relevance, as we have
tried to do in the case of children with RAOM with OME aged
>3 years (see Figure 1).
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